BARETab Nutra DS is a novel Co-Processed excipients which is a combination of three Pharmacopeial excipients made by Co-Processing Technology. BARETab Nutra DS contains Dibasic Calcium Phosphate Anhydrous [DCPA] (Filler), Microcrystalline Cellulose (Binder) and Crosscarmellose Sodium (Disintegrant). BARETab Nutra DS offers excellent compressibility, good flowability with higher tablet hardness with less percentage friability and less disintegration time as compared to physical mixing and individual excipients.
This is the main requirement for Direct Compression (DC) tablet formulation mainly in Nutraceutical tablet formulation. However, most individual excipients have insufficient physical characteristics, particularly in flowability and compressibility. Co-processed excipients are beginning to be used in the manufacturing of tablets and capsules to fulfill these requirements. All co-processed excipients have excellent flowability and higher compressibility and they have now carved out a niche for themselves in the Pharmaceutical and Nutraceutical sectors.
In this study, We will make a Placebo Tablet of BARETab Nutra DS, Physical Blend, and Individual Excipient (MCC) by using direct compression method at the same thickness and same tablet weight and evaluate in-vitro parameters such as Weight Uniformity, Tablet Hardness, Friability and Disintegration time. BARETab Nutra DS is a high-functionality excipients to provides excellent tablet hardness, less friability and less disintegration time with superior flowability.
Download the full article as PDF here: The Role of BARETab Nutra DS in Direct Tablet Compression Method
Materials
HiCel binder and BARETab Nutra DS manufactured at Sigachi Industries Ltd. in Dahej, Gujarat, Filler Purchased from SBF Pharma, Ahmedabad, Gujarat, Disintegrant Purchased from Ascot Pharma, Ahmedabad, Gujarat and others chemicals are AR grade used in this study.
Rauf Pathan(Sigachi Industries Limited), Monika Tomar and Amit Raj Sinha, The Role of BARETab Nutra DS in Direct Tablet Compression Method, Article Received on 17 Jan. 2024, Revised on 07 Feb. 2024, Accepted on 27 Feb. 2024, DOI: 10.20959/wjpr20245-31066
Read the interesting article Introduction to Tablets in Nutraceuticals here:
